Chorionic villus Sampling (CVS) is an early pregnancy diagnostic test that examines placental tissue to identify certain ...

This week’s Bulls N’ Bears ASX Runner of the Week is… Identifai, after the Israeli biotech newcomer made a stellar debut on the ASX with its AI-powered prenatal screening technology.

"Should I get NIPT?" and "How exactly is it different from amniocentesis?"—consultations regarding prenatal diagnosis are ...

Evidence highlights the challenges of non-RhD alloimmunization and the limitations of cell-free DNA testing for fetal antigen ...

Identifai Genetics (ASX:IDG) is heading for an ASX listing with a US$2.2m loss, a US$1m cash balance, and a prenatal test ...

An new analysis highlights serious gaps in FNAIT support and provides perinatal care providers with an enhanced understanding ...

A local midwife is sharing her daughter Connie's story to raise vital awareness of baby loss and rare mitochondrial disease ...